Press Releases

Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, announces today that it has successfully completed a phase III clinical trial in adult and paediatric patients with impetigo involving Ozenoxacin formulated as a topical...

Biogen Idec Inc. announced today that its 2013 Annual Shareholder Meeting will be webcast live on Wednesday June 12 2013 at 9:00 a.m. ET. To access the live webcast please visit Biogen Idec’s Investors section at www.biogenidec.com. An archived...

Novasep, a leading supplier of manufacturing solutions to the life sciences industry, announces it has strengthened its position in the fine chemicals marketplace with the appointment of Udo Steinhauer as fine chemicals market director within the synthesis business unit...

The UAE is currently witnessing progress in the global medical tourism industry today. Being a melting pot of cultures and located only a few hours away from one third of the world’s population, the country is increasingly becoming...

The BBRSC Programme combines Chemistry and Biochemical Engineering at UCL with Almac’s Biocatalysis Group. The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically...

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and the Roche Institute for Research and Translational Medicine are strengthening their collaborative efforts. In 2009, the Institut Curie and Roche signed an initial...

Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes. ...